Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRME for Cervical Cancer Prevention
NCT02714439Phase 1Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Oct 2016
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Diagnostic Accuracy of the High-Resolution Microendoscopy (HRME) at 1 day. Started Oct 2016; status: terminated.
Beyond the preview
Go deeper on NCT02714439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714439.